Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer

Clinical Cancer Research

Volumn 3, Issue 9, 1997, Pages 1593-1598

  Dalbagni, Guido ^a   Han, Wei ^a   Zhang, Zuo Feng ^a   Cordon Cardo, Carlos ^a   Saigo, Patricia ^a   Fair, William R ^a   Herr, Harry ^a   Kim, Nam ^b   Moore, Malcolm A S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GERON CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CYTOPATHOLOGY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; TELOMERE; URINALYSIS;

CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DNA, NEOPLASM; HUMANS; IRRIGATION; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TELOMERASE; TELOMERE; THERAPEUTIC IRRIGATION; TUMOR STEM CELLS; URINARY BLADDER NEOPLASMS; URINE;

EID: 0030860566     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1996. CA Cancer J. Clin., 65: 5-27, 1996.
2. Reuter, V. E., and Melamed, M. R. The lower urinary tract. In: S. Sternberg (ed.), Diagnostic Surgical Pathology, pp. 1767-1805. New York: Raven Press, 1994.
3. Soloway, M. S. Overview of treatment of superficial bladder cancer. Urol. Suppl., 26: 18-27, 1985.
4. Hemstreet, G. P., Bonner, R. B., Hurst, R., and O'Dowd, G. J. Cytology of bladder cancer. N. J. Vogelzang, P. T. Scardino, W. U. Shipley, and D. S. Coffey (eds.), Comprehensive Textbook of Genito-urinary Oncology, pp. 338-350. Baltimore: Williams & Wilkins, 1996.
5. Farrow, G. M. Urine cytology of transitional cell carcinoma. G. L. Weid, C. M. Keebler, L. G. Koss, S. F. Patten, and D. L. Rosenthal (eds.), Compendium of Diagnostic Cytology, 6th ed., pp. 410-416. Chicago: International Academy of Cytology, 1988.
6. Murphy, W. M., Soloway, M. S., Jukkola, A. F., Crabtree, W. N., and Ford, K. S. Urinary cytology and bladder cancer. Cancer (Phila.), 53: 1555-1565, 1984.
7. Sheinfeld, J., Reuter, V. E., Melamed, M. R., Fair, W. R., Morse, M., Sogani, P. C., Herr, H. W., Whitmore, W. F., and Cordon-Cardo, C. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J. Urol., 143: 285-288, 1990.
8. Golijanin, D., Sherman, Y., Shapiro, A., and Pode, D. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine. Urology, 46: 173-177, 1995.
9. Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D., and Sidransky, D. Molecular detection of primary bladder cancer by microsatellite analysis. Science (Washington DC), 271: 659-662, 1996.
10. Sarosdy, M. F., DeVere White, R. W., Soloway, M. S., Sheinfeld, J., Hudson, M. A., Schellhammer, P. F., Jarowenko, M. V., Adams, G., and Blumenstein, B. A. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol., 154: 379-384, 1995.
11. D'Hallewin, M-A., and Baert, L. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J. Urol., 155: 475-476, 1996.
12. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC) 266: 2011-2015, 1994.
13. Tahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res., 55: 2734-2736, 1995.
14. Counter, C. M., Hirte, H. W., Bacchetti, S., and Harley, C. B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA, 91: 2900-2904, 1994.
15. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Telomerase activity in small cell and non-small cell lung cancers. J. Natl. Cancer Inst., 87: 895-902, 1995.
16. Lin, Y., Miyamoto, H., Fujinami, K., Uemura, H., Hosaka, M., Iwasaki, Y., and Kubota, Y. Telomerase activity in human bladder cancer. Clin. Cancer Res., 2: 929-932, 1996.
17. Kim, N., and Wu, F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res., 25: 2595-2597, 1997.
18. Farrow, G. M. Urine cytology in the detection of bladder cancer: a critical approach. J. Occup. Med., 32: 817-821, 1990.
19. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., and Howkins, I. R. Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083-1086, 1983.
20. Klein, F. A., Herr, H. W., Sogani, P. A., Whitmore, W. F., and Melamed, M. R. Flow cytometry of normal and nonneoplastic disease of the bladder: an estimate of the false positive rate. J. Urol., 127: 946-948, 1982.
21. Muller, M., Heine, B., Heicappell, R., Emrich, T., Hummel, M., Stein, H., and Miller, K. Telomerase activity in bladder cancer, bladder washings and in urine. Int. J. Oncol., 9: 1169-1173, 1996.
22. Yoshida, K., Sugino, T., Tahara, H., Woodman, A., Bolodeoku, J., Nargund, V., Fellows, G., Goodison, S., Tahara, E., and Tarin, D. Telomerase activity in bladder carcinoma and its implication for non-invasive diagnosis by detection of exfoliated cancer cells in urine. Cancer (Phila.), 79: 362-369, 1997.
23. Carrington Reid, M., Lachs, M. S., and Feinstein, A. R. Use of methodological standards in diagnostic test research: getting better but still not good. J. Am. Med. Assoc., 275: 645-651, 1995.